Kato N - Search Results

1

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.

Otsuka M, Kato N, Lan K, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M. Otsuka M, et al. Among authors: kato j, kato n. J Biol Chem. 2000 Nov 3;275(44):34122-30. doi: 10.1074/jbc.M000578200. J Biol Chem. 2000. PMID: 10924497 Free article.

2

Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Kato N, et al. J Virol. 1997 Nov;71(11):8856-9. doi: 10.1128/JVI.71.11.8856-8859.1997. J Virol. 1997. PMID: 9343247 Free PMC article.

3

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. Kato N, et al. Among authors: kato j. Hepatology. 2000 Aug;32(2):405-12. doi: 10.1053/jhep.2000.9198. Hepatology. 2000. PMID: 10915750

4

Large isoform of hepatitis delta antigen activates serum response factor-associated transcription.

Goto T, Kato N, Ono-Nita SK, Yoshida H, Otsuka M, Shiratori Y, Omata M. Goto T, et al. Among authors: kato n. J Biol Chem. 2000 Dec 1;275(48):37311-6. doi: 10.1074/jbc.M002947200. J Biol Chem. 2000. PMID: 10961986 Free article.

5

Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor.

Yoshida H, Kato N, Shiratori Y, Otsuka M, Maeda S, Kato J, Omata M. Yoshida H, et al. Among authors: kato j, kato n. J Biol Chem. 2001 May 11;276(19):16399-405. doi: 10.1074/jbc.M006671200. Epub 2001 Feb 5. J Biol Chem. 2001. PMID: 11278312 Free article.

6

Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon.

Shiratori Y, Kato N, Yokosuka O, Hashimoto E, Hayashi N, Nakamura A, Asada M, Kuroda H, Ohkubo H, Arakawa Y, Iwama A, Omata M. Shiratori Y, et al. Among authors: kato n. J Hepatol. 1997 Sep;27(3):437-44. doi: 10.1016/s0168-8278(97)80346-7. J Hepatol. 1997. PMID: 9314119

7

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Among authors: kato n. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

8

How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? Tokyo-Chiba Hepatitis Research Group.

Shiratori Y, Kato N, Yoshida H, Imazeki F, Okano K, Yokosuka O, Omata M. Shiratori Y, et al. Among authors: kato n. J Gastroenterol Hepatol. 1999 Jan;14(1):79-84. doi: 10.1046/j.1440-1746.1999.01802.x. J Gastroenterol Hepatol. 1999. PMID: 10029282

9

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Ono-Nita SK, Kato N, Shiratori Y, Masaki T, Lan KH, Carrilho FJ, Omata M. Ono-Nita SK, et al. Among authors: kato n. Hepatology. 1999 Mar;29(3):939-45. doi: 10.1002/hep.510290340. Hepatology. 1999. PMID: 10051501

10

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Carrilho FJ, Omata M. Ono-Nita SK, et al. Among authors: kato n. J Clin Invest. 1999 Jun;103(12):1635-40. doi: 10.1172/JCI5882. J Clin Invest. 1999. PMID: 10377169 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,930 results

Search Page

Filters